[Adrenergic beta receptor blockaders].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000758:Anesthesia / Q000009:adverse effects; D001249:Asthma; D001986:Bronchial Spasm / Q000139:chemically induced; D003231:Conjunctivitis / Q000139:chemically induced; D007003:Hypoglycemia / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D007634:Keratitis / Q000139:chemically induced; D007674:Kidney Diseases; D011217:Practolol / Q000009:adverse effects*; D011433:Propranolol / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced; D014652:Vascular Diseases / Q000139:chemically induced
D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D011217:Practolol
Medikamentell terapi i praksis